Quent Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$155K Sell
2,162
-107
-5% -$8.24K 0.01% 440
2025
Q4
$180K Buy
2,269
+207
+10% +$16.3K 0.01% 414
2025
Q3
$155K Buy
+2,062
New +$141K 0.01% 323
2025
Q2
Sell
-1,646
Closed -$112K 504
2025
Q1
$112K Sell
1,646
-383
-19% -$22.9K 0.01% 370
2024
Q4
$91.1K Sell
2,029
-906
-31% -$50.8K 0.01% 437
2024
Q3
$184K Sell
2,935
-1,563
-35% -$91.2K 0.02% 357
2024
Q2
$266K Sell
4,498
-1,953
-30% -$122K 0.03% 261
2024
Q1
$515K Buy
6,451
+418
+7% +$31.9K 0.06% 174
2023
Q4
$476K Buy
6,033
+47
+0.8% +$3.35K 0.06% 174
2023
Q3
$418K Sell
5,986
-315
-5% -$22.3K 0.07% 170
2023
Q2
$436K Sell
6,301
-22
-0.3% -$1.56K 0.07% 170
2023
Q1
$470K Buy
6,323
+85
+1% +$7.13K 0.08% 151
2022
Q4
$581K Buy
6,238
+294
+5% +$28.4K 0.11% 121
2022
Q3
$567K Buy
5,944
+116
+2% +$11.5K 0.12% 114
2022
Q2
$540K Buy
5,828
+210
+4% +$20.5K 0.12% 112
2022
Q1
$569K Buy
5,618
+1,361
+32% +$143K 0.11% 132
2021
Q4
$439K Buy
+4,257
New +$393K 0.09% 179

Other funds holding CVS

Quent Capital's CVS Position: Q1 2026 in Review

Quent Capital reduced its CVS Health (CVS) stake by 4.7% in Q1 2026, selling an estimated $8.24K and leaving 2,162 shares worth $155K. The position accounts for 0.01% of the portfolio, ranked #440.

Quent Capital first reported a position in CVS in Q4 2021 and has held it in 17 quarters since. The position peaked at $581K in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Quent Capital held 2,162 shares of CVS Health worth $155K as of Q1 2026.
  • Quent Capital sold 107 CVS Health shares in Q1 2026, an estimated $8.24K.
  • CVS Health made up 0.01% of Quent Capital's portfolio in Q1 2026, its #440 holding.
  • Quent Capital first reported a position in CVS Health in Q4 2021 and has held it in 17 quarters since.
  • Quent Capital's CVS Health position peaked at $581K in Q4 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.